Fredun Pharmaceuticals Q2 revenue rises 85% to ₹266 crore
In short
The company said better demand helped the results.
This matters for investors because it points to stronger sales and profits at the company.
What the reporting says
The brief links the gain to better demand. No further financial details are provided in the source snippet.
Why it matters
The source attributes the performance to better demand. The update is relevant to shareholders and market watchers tracking the company’s operating momentum, but no other segment, margin, or balance-sheet figures are given.